Impact of Head and Neck Cancer Adaptive Radiotherapy to Spare the Parotid Glands and Decrease the Risk of Xerostomia

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2015 Jan 10

PMID 25573091

Citations 60

Authors

Joel Castelli

Antoine Simon

Guillaume Louvel

Olivier Henry

Enrique Chajon

Mohamed Nassef

Pascal Haigron

Guillaume Cazoulat

Juan David Ospina

Franck Jegoux

Karen Benezery

Renaud de Crevoisier

Affiliations

Soon will be listed here.

Abstract

Background: Large anatomical variations occur during the course of intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNC). The risks are therefore a parotid glands (PG) overdose and a xerostomia increase. The purposes of the study were to estimate: - the PG overdose and the xerostomia risk increase during a "standard" IMRT (IMRTstd); - the benefits of an adaptive IMRT (ART) with weekly replanning to spare the PGs and limit the risk of xerostomia.

Material And Methods: Fifteen patients received radical IMRT (70 Gy) for LAHNC. Weekly CTs were used to estimate the dose distributions delivered during the treatment, corresponding either to the initial planning (IMRTstd) or to weekly replanning (ART). PGs dose were recalculated at the fraction, from the weekly CTs. PG cumulated doses were then estimated using deformable image registration. The following PG doses were compared: pre-treatment planned dose, per-treatment IMRTstd and ART. The corresponding estimated risks of xerostomia were also compared. Correlations between anatomical markers and dose differences were searched.

Results: Compared to the initial planning, a PG overdose was observed during IMRTstd for 59% of the PGs, with an average increase of 3.7 Gy (10.0 Gy maximum) for the mean dose, and of 8.2% (23.9% maximum) for the risk of xerostomia. Compared to the initial planning, weekly replanning reduced the PG mean dose for all the patients (p<0.05). In the overirradiated PG group, weekly replanning reduced the mean dose by 5.1 Gy (12.2 Gy maximum) and the absolute risk of xerostomia by 11% (p<0.01) (30% maximum). The PG overdose and the dosimetric benefit of replanning increased with the tumor shrinkage and the neck thickness reduction (p<0.001).

Conclusion: During the course of LAHNC IMRT, around 60% of the PGs are overdosed of 4 Gy. Weekly replanning decreased the PG mean dose by 5 Gy, and therefore by 11% the xerostomia risk.

Citing Articles

Adaptive radiotherapy in locally advanced head and neck cancer: The importance of reduced margins.

Enocson H, Haraldsson A, Engstrom P, Ceberg S, Gebre-Medhin M, Adrian G Phys Imaging Radiat Oncol. 2025; 33:100696.

PMID: 39897022 PMC: 11787698. DOI: 10.1016/j.phro.2025.100696.

Retrospective Comparison of Geometrical Accuracy among Atlas-based Auto-segmentation, Deep Learning Auto-segmentation, and Deformable Image Registration in the Treatment Replanning for Adaptive Radiotherapy of Head-and-Neck Cancer.

Nagayasu Y, Inui S, Ueda Y, Masaoka A, Tominaga M, Miyazaki M J Med Phys. 2024; 49(3):335-342.

PMID: 39526151 PMC: 11548068. DOI: 10.4103/jmp.jmp_39_24.

Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review.

Simopoulou F, Kyrgias G, Georgakopoulos I, Avgousti R, Armpilia C, Skarlos P Medicine (Baltimore). 2024; 103(26):e38529.

PMID: 38941415 PMC: 11466102. DOI: 10.1097/MD.0000000000038529.

TransAnaNet: Transformer-based Anatomy Change Prediction Network for Head and Neck Cancer Patient Radiotherapy.

Chen M, Wang K, Dohopolski M, Morgan H, Sher D, Wang J ArXiv. 2024; .

PMID: 38764596 PMC: 11100917.

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy.

Kutuk T, Atak E, Villa A, Kalman N, Kaiser A Curr Oncol. 2024; 31(4):2092-2108.

PMID: 38668058 PMC: 11049200. DOI: 10.3390/curroncol31040155.

References

Duma M, Kampfer S, Schuster T, Winkler C, Geinitz H . Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol. 2012; 188(3):243-7. DOI: 10.1007/s00066-011-0041-8. View

Wu Q, Chi Y, Chen P, Krauss D, Yan D, Martinez A . Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys. 2009; 75(3):924-32. DOI: 10.1016/j.ijrobp.2009.04.047. View

Budach W, Bolke E, Fietkau R, Buchali A, Wendt T, Popp W . Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol. 2011; 187(8):449-60. DOI: 10.1007/s00066-011-2273-z. View

Berwouts D, Olteanu L, Duprez F, Vercauteren T, De Gersem W, De Neve W . Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial. Radiother Oncol. 2013; 107(3):310-6. DOI: 10.1016/j.radonc.2013.04.002. View

LYMAN J . Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 1985; 8:S13-9. View

Schwartz D, Garden A, Shah S, Chronowski G, Sejpal S, Rosenthal D . Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. Radiother Oncol. 2013; 106(1):80-4. DOI: 10.1016/j.radonc.2012.10.010. View

Castadot P, Lee J, Parraga A, Geets X, Macq B, Gregoire V . Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. Radiother Oncol. 2008; 89(1):1-12. DOI: 10.1016/j.radonc.2008.04.010. View

Lai Y, Yang S, Liang J, Wang Y, Yu C, Su C . Impact of body-mass factors on setup displacement in patients with head and neck cancer treated with radiotherapy using daily on-line image guidance. Radiat Oncol. 2014; 9:19. PMC: 3904466. DOI: 10.1186/1748-717X-9-19. View

Kam M, Leung S, Zee B, Chau R, Suen J, Mo F . Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007; 25(31):4873-9. DOI: 10.1200/JCO.2007.11.5501. View

10.

Daisne J, Blumhofer A . Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation. Radiat Oncol. 2013; 8:154. PMC: 3722083. DOI: 10.1186/1748-717X-8-154. View

11.

Mohan R, Wu Q, Manning M, Schmidt-Ullrich R . Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000; 46(3):619-30. DOI: 10.1016/s0360-3016(99)00438-1. View

12.

Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T . Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer. 2013; 13:84. PMC: 3599345. DOI: 10.1186/1471-2407-13-84. View

13.

Henriksson R, Frojd O, Gustafsson H, Johansson S, Franzen L, Bjermer L . Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. Br J Cancer. 1994; 69(2):320-6. PMC: 1968701. DOI: 10.1038/bjc.1994.58. View

14.

Barker Jr J, Garden A, Ang K, ODaniel J, Wang H, Court L . Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004; 59(4):960-70. DOI: 10.1016/j.ijrobp.2003.12.024. View

15.

Castadot P, Geets X, Lee J, Gregoire V . Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort?. Radiother Oncol. 2011; 101(3):343-50. DOI: 10.1016/j.radonc.2011.06.011. View

16.

Lombaert I, Brunsting J, Wierenga P, Faber H, Stokman M, Kok T . Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One. 2008; 3(4):e2063. PMC: 2329592. DOI: 10.1371/journal.pone.0002063. View

17.

Hansen E, Bucci M, Quivey J, Weinberg V, Xia P . Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005; 64(2):355-62. DOI: 10.1016/j.ijrobp.2005.07.957. View

18.

Porter S, Fedele S, Habbab K . Xerostomia in head and neck malignancy. Oral Oncol. 2010; 46(6):460-3. DOI: 10.1016/j.oraloncology.2010.03.008. View

19.

Thirion J . Image matching as a diffusion process: an analogy with Maxwell's demons. Med Image Anal. 1999; 2(3):243-60. DOI: 10.1016/s1361-8415(98)80022-4. View

20.

Guily J, Borget I, Vainchtock A, Remy V, Takizawa C . Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database. Head Neck Oncol. 2010; 2:22. PMC: 2942880. DOI: 10.1186/1758-3284-2-22. View